Related Experiment Video
Updated: May 15, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Clinical progress note: Haemophilus influenzae type b
Anne Ewing1, Sydney Haldeman1, Adam J Ratner2
1Department of Pediatrics, NYU Grossman School of Medicine, New York, New York, USA.
Abstract:
Vaccine-preventable diseases that have yet to be eliminated are important to review for the practicing clinician. Haemophilus influenzae type b (Hib) was once the leading cause of bacterial meningitis in young children and now causes rare invasive disease in young children and the elderly. Patients with immunodeficiency and impaired complement response to encapsulated organisms (e.g., sickle cell disease; asplenia) are at particular risk of invasive Hib disease. Recognition of a potential case, prompt management and reporting, and inpatient vaccine administration and education are crucial actions for hospitalists in the management of Hib disease and prevention.
Related Concept Videos
Stages of Infection
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

